Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review. JOHMPE [Internet]. 2025(e)ko otsailaren 27(e)an [aipatua 2026(e)ko abuztuaren 25(e)an];3(1). Available at: https://shmpublisher.com/index.php/johmpe/article/view/547